SCHEMBL24876155

SCHEMBL24876155

Cc1cc2[nH]c(=O)c(=O)[nH]c2c(F)c1S(=O)(=O)Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 13/20 0.49
GRIN2D O15399 10/20 0.49
GRIN3B O60391 10/20 0.49
GRIN2A Q12879 10/20 0.49
GRIN2B Q13224 10/20 0.49
GRIN2C Q14957 10/20 0.49
GRIN3A Q8TCU5 10/20 0.49
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
GRIA4 P48058 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24876146 0.73 GRIN1 (0.50) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL24876758 0.72 LMNA (0.52) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL5973354 0.70 GRIN1 (0.67) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL640928 0.69 PTGS1 (0.38) MAPK1
SCHEMBL24875976 0.69 GRIN2D (0.59) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL30210932 0.69 GRIN2D (0.59) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7786608 0.67 GRIN2D (0.65) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7784266 0.66 GRIN2D (0.69) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL31566805 0.66 GRIN2D (0.33) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7346405 0.66 GRIN2D (1.00) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367103-B1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-09-03 EP disclosed
US-20240376084-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (DE) 2024-11-14 US disclosed
EP-4367103-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2024-05-15 EP disclosed
WO-2023280970-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-01-12 WO disclosed
WO-2023280970-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376084-A1 INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS SERPINB1, LTA, SERPINC1 GRIN1 4494/4885GRIN2D 4864/4885GRIN3B 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.